These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10223949)

  • 21. A review: the active peptide of lactoferrin.
    Tomita M; Takase M; Bellamy W; Shimamura S
    Acta Paediatr Jpn; 1994 Oct; 36(5):585-91. PubMed ID: 7825467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin.
    Bellamy W; Takase M; Wakabayashi H; Kawase K; Tomita M
    J Appl Bacteriol; 1992 Dec; 73(6):472-9. PubMed ID: 1490908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of amino acid substitutions on the candidacidal activity of LFampin 265-284.
    van der Kraan MI; van der Made C; Nazmi K; van't Hof W; Groenink J; Veerman EC; Bolscher JG; Nieuw Amerongen AV
    Peptides; 2005 Nov; 26(11):2093-7. PubMed ID: 15946771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-complement effects of lactoferrin-derived peptides.
    Samuelsen Ø; Haukland HH; Ulvatne H; Vorland LH
    FEMS Immunol Med Microbiol; 2004 Jun; 41(2):141-8. PubMed ID: 15145458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin.
    Hwang PM; Zhou N; Shan X; Arrowsmith CH; Vogel HJ
    Biochemistry; 1998 Mar; 37(12):4288-98. PubMed ID: 9521752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent studies on the antimicrobial peptides lactoferricin and lactoferrampin.
    Yin C; Wong JH; Ng TB
    Curr Mol Med; 2014; 14(9):1139-54. PubMed ID: 25324002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibacterial activity of multiple antigen peptides homologous to a loop region in human lactoferrin.
    Azuma M; Kojima T; Yokoyama I; Tajiri H; Yoshikawa K; Saga S; Del Carpio CA
    J Pept Res; 1999 Sep; 54(3):237-41. PubMed ID: 10517161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans.
    Chen HL; Yen CC; Lu CY; Yu CH; Chen CM
    J Agric Food Chem; 2006 May; 54(9):3277-82. PubMed ID: 16637685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Very Short and Stable Lactoferricin-Derived Antimicrobial Peptides: Design Principles and Potential Uses.
    Svendsen JSM; Grant TM; Rennison D; Brimble MA; Svenson J
    Acc Chem Res; 2019 Mar; 52(3):749-759. PubMed ID: 30829472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Important structural features of 15-residue lactoferricin derivatives and methods for improvement of antimicrobial activity.
    Strøm MB; Haug BE; Rekdal O; Skar ML; Stensen W; Svendsen JS
    Biochem Cell Biol; 2002; 80(1):65-74. PubMed ID: 11908644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased antibacterial activity of 15-residue murine lactoferricin derivatives.
    Strøm MB; Rekdal O; Stensen W; Svendsen JS
    J Pept Res; 2001 Feb; 57(2):127-39. PubMed ID: 11168896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment.
    Yamauchi K; Tomita M; Giehl TJ; Ellison RT
    Infect Immun; 1993 Feb; 61(2):719-28. PubMed ID: 8423097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti herpes simplex virus activity of lactoferrin/lactoferricin -- an example of antiviral activity of antimicrobial protein/peptide.
    Jenssen H
    Cell Mol Life Sci; 2005 Dec; 62(24):3002-13. PubMed ID: 16261265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different anti-Candida activities of two human lactoferrin-derived peptides, Lfpep and kaliocin-1.
    Viejo-Díaz M; Andrés MT; Fierro JF
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2583-8. PubMed ID: 15980323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bactericidal activity of LFchimera is stronger and less sensitive to ionic strength than its constituent lactoferricin and lactoferrampin peptides.
    Bolscher JG; Adão R; Nazmi K; van den Keybus PA; van 't Hof W; Nieuw Amerongen AV; Bastos M; Veerman EC
    Biochimie; 2009 Jan; 91(1):123-32. PubMed ID: 18573310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial activity of immobilized lactoferrin and lactoferricin.
    Chen R; Cole N; Dutta D; Kumar N; Willcox MDP
    J Biomed Mater Res B Appl Biomater; 2017 Nov; 105(8):2612-2617. PubMed ID: 27758034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibacterial action of lactoferricin B like peptide against Escherichia coli: reactive oxygen species-induced apoptosis-like death.
    Lee B; Hwang JS; Lee DG
    J Appl Microbiol; 2020 Aug; 129(2):287-295. PubMed ID: 32145045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of iron/ascorbate-induced lipid peroxidation by an N-terminal peptide of bovine lactoferrin and its acylated derivatives.
    Wakabayashi H; Matsumoto H; Hashimoto K; Teraguchi S; Takase M; Hayasawa H
    Biosci Biotechnol Biochem; 1999 May; 63(5):955-7. PubMed ID: 10380640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of endotoxin neutralization by coupling of a C12-alkyl chain to a lactoferricin-derived peptide.
    Andrä J; Lohner K; Blondelle SE; Jerala R; Moriyon I; Koch MH; Garidel P; Brandenburg K
    Biochem J; 2005 Jan; 385(Pt 1):135-43. PubMed ID: 15344905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of a novel antimicrobial peptide activated by virulent proteases.
    Aoki W; Kitahara N; Miura N; Morisaka H; Kuroda K; Ueda M
    Chem Biol Drug Des; 2012 Nov; 80(5):725-33. PubMed ID: 22863111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.